Strategic acquisitions Recent acquisition activity by DoseMe of Firstline signals a shift in ownership and potential integration opportunities. Engage with DoseMe and the acquiring entity to map current and future product alignment, cross-sell antimicrobial stewardship and clinical decision support features, and explore co-marketing or pilot collaborations with hospitals already using both platforms.

Global expansion Firstline has global hospital and health system reach and partners with organizations worldwide, including NYC Health + Hospitals and WHO collaborations. Target expansion into additional large health systems and international markets by demonstrating the platform’s ability to localize guidelines, support antimicrobial stewardship, and integrate local antibiogram data for informed prescribing.

Public sector partnerships Partnerships with WHO and large public health systems indicate strong public sector credibility. Leverage this by positioning Firstline for enterprise ID guideline standardization projects, compliance-driven deployments, and national or regional AMR containment initiatives that require centralized, up-to-date decision support across facilities.

Productized Community The Firstline Community offers a free platform for ID professionals to share guidelines and discuss best practices. Sales opportunities exist to upsell premium collaboration features, training, and enterprise-ready integrations for organizations seeking formalized governance of guidelines and extended antimicrobial stewardship resources within institutional deployments.

Financial scale With reported revenue in the multi–million range and a mid-sized employee base, Firstline represents a scalable platform ready for expansion into larger hospital networks. Focus outreach on mid-to-large health systems and multisite networks that require scalable, customizable ID decision support, local guideline localization, and robust formulary data to drive adoption.